Anavex Life Sciences Corp. (AVXL)
Market Closed
16 Oct, 08:00 PM
$
1. 31
-0.17
-11.4865%
$
142.71M Market Cap
- P/E Ratio
- Div Yield
1.47M Volume
-0.63 Eps
$ 1.48
Previous Close 
Want to track AVXL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Anavex Life Sciences Corp. (AVXL) Statistics
Valuation metrics
Market Cap 142.71M
Enterprise value 19.75M
Trailing P/E (ttm) -5.7
Forward P/E -25
PEG ratio -0.07
Price/Sales (ttm) -
Price/Book (mrq) 1.21
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.91
Overview
Shares outstanding 92.67M
Float 89.78M
Shares short 19.26M
% Held by insiders 0.03%
% Held by institutions 0.42%
Average volume (10 days) 1.85M
Average volume (90 days) 1.3M
Price summary
52-Week low 1.3
52-Week high 9.5
Beta 1.18
50-Day moving average 2.04
200-Day moving average 2.81
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 7 Oct 2015
Financials
Fiscal year
Fiscal year ends 30 Sep 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.2%
Return on equity -0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -39.95M
Diluted EPS (ttm) -0.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 131.75M
Total cash per share (mrq) 1.29
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 15.62%
Book value per share (mrq) 1.23
Cash Flow
Cash flow statement -34.08M
Levered free cash flow (LFCF) -21.83M
2026 © Marketlog. All Rights Reserved.
